KS-V Peptide

KS-V Peptide was founded in 2018 by three internationally renowned scientists from China University of Science and Technology, Tsinghua University, and Nankai University. Our company has several cutting-edge core technologies and four major platforms, including peptide synthesis platform, phage-display assisted peptide drug discovery platform, structural biology platform, as well as pre-clinical testing platform. We can offer comprehensive support for integrated drug discovery and development services. KS-V Peptide has provided peptide services to over 1,000 academic clients and100 industrial clients from more than 30 countries. We are committed to promoting innovation to support drug research and development, as well as healthy living. At KS-V Peptide, we are excited to collaborate with clients around the world to create innovative partnerships.